A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
复制标题
对密歇根州青少年接种疫苗相关因素的人口水平评估。
DOI：
10.1016/j.jadohealth.2013.07.022
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Dempsey,AmandaF
中科院分区：
文献类型：
--
作者：
Gowda,Charitha;Dong,Shiming;Potter,RachelC;Dombkowski,KevinJ;Dempsey,AmandaF
目的需要增加青少年疫苗接种覆盖率。本研究的目的是确定人口水平的临床和人口统计学因素与青少年vaccination.MethodsA从密歇根州护理改善登记处（MCIR），全州范围内的免疫登记处的数据进行了回顾性分析，为2006-2010年。样本包括1，252，655名11-18岁的青少年。计算了破伤风-白喉-无细胞百日咳（Tdap）、脑膜炎球菌结合物（MCV 4）、流感（季节性流感）和人乳头瘤病毒（仅限女性）疫苗的疫苗覆盖率。对于参加医疗补助的青少年的子集，索赔数据被用来获得有关的访问类型，其中疫苗administered.ResultsAs的信息，截至2010年，全州范围内的覆盖水平Tdap和MCV 4疫苗分别为46.0%和46.5%，而只有15%的女性完成了HPV疫苗系列。只有四分之一的女性青少年接种了所有三种疫苗。在2009-2010年期间，全州青少年流感疫苗的覆盖率为8%。年龄是HPV疫苗接种的最重要预测因素，而卫生保健相关因素（提供者类型和儿童免疫史）是其他三种疫苗的最强预测因素。年龄较大的青少年接受流感疫苗的可能性较小，但比年轻的青少年更有可能接受HPV疫苗剂量。在参加医疗补助的青少年，大多数Tdap，MCV，和第一剂HPV疫苗，但只有29%的流感剂量，在预防visits.ConclusionsNoted青少年疫苗覆盖率的变化，年龄，疫苗类型，和卫生保健相关因素提供了一个框架，为发展未来的推广活动，以增加青少年疫苗的使用。
PurposeIncreases in adolescent vaccine coverage are needed. The aim of this study was to identify population-level clinical and demographic factors associated with adolescent vaccination.MethodsA retrospective analysis of data from the Michigan Care Improvement Registry (MCIR), a statewide immunization registry, was performed for 2006–2010. The sample included 1,252,655 adolescents aged 11–18 years. Vaccine coverage levels were calculated for tetanus–diphtheria–acellular pertussis (Tdap), meningococcal conjugate (MCV4), flu (seasonal influenza), and human papillomavirus, females only (HPV) vaccines. For the subset of adolescents enrolled in Medicaid, claims data were used to obtain information about the type of visits in which vaccines were administered.ResultsAs of 2010, statewide coverage levels for Tdap and MCV4 vaccines were 46.0% and 46.5%, respectively whereas only 15% of females had completed the HPV vaccine series. Only one in four female adolescents were up to date for all three of these vaccines. Statewide coverage among adolescents for flu vaccine during the 2009–2010 season was 8%. Age was the most significant predictor of HPV vaccination, whereas health care–associated factors (provider type and childhood immunization history) were the strongest predictors for the other three vaccines. Older adolescents were less likely to have received the flu vaccine but more likely to have receive HPV vaccine doses than younger adolescents. Among Medicaid-enrolled adolescents, most Tdap, MCV, and first-dose HPV vaccines, but only 29% of flu doses, were administered during preventive visits.ConclusionsNoted variability in adolescent vaccine coverage by age, vaccine type, and health care–associated factors provides a framework for developing future outreach activities to increase adolescent vaccine use.